Hyperliquid Strategies files S-1 with SEC seeking up to $1 billion, planning Nasdaq listing under “PURR.” HYPE token surged nearly 10% after the filing, reflecting strong investor interest and optimism. Hyperliquid Strategies has submitted an S-1 filing with the U.S. Securities and Exchange Commission (SEC) to raise up to $1 billion through a public stock [...]]]>Hyperliquid Strategies files S-1 with SEC seeking up to $1 billion, planning Nasdaq listing under “PURR.” HYPE token surged nearly 10% after the filing, reflecting strong investor interest and optimism. Hyperliquid Strategies has submitted an S-1 filing with the U.S. Securities and Exchange Commission (SEC) to raise up to $1 billion through a public stock [...]]]>

Hyperliquid Strategies Files S-1 to Raise Up to $1 Billion via Chardan Equity Facility

2025/10/23 16:56
  • Hyperliquid Strategies files S-1 with SEC seeking up to $1 billion, planning Nasdaq listing under “PURR.”
  • HYPE token surged nearly 10% after the filing, reflecting strong investor interest and optimism.

Hyperliquid Strategies has submitted an S-1 filing with the U.S. Securities and Exchange Commission (SEC) to raise up to $1 billion through a public stock offering.

The firm aims to issue up to 160 million common shares in this initiative, with Chardan Capital Markets acting as the financial advisor.

The filing states that the funds raised will be used for general business operations and potential purchases of HYPE tokens. The company currently holds around 12.6 million HYPE tokens.

The company stated,

Hyperliquid Strategies Files S-1 to Raise Up to $1 Billion via Chardan Equity FacilitySource: .sec.gov

Hyperliquid Targets Nasdaq Listing Under “PURR”

Hyperliquid Strategies was established through a pending merger between Nasdaq-listed Sonnet BioTherapeutics and Rorschach I LLC, a special purpose acquisition company. The merged company will be led by David Schamis as Chief Executive, while Bob Diamond, the former CEO of Barclays, will assume the role of Chairman.

The merger is expected to be completed before the end of the year.  Once finalized, Hyperliquid will list on the Nasdaq Capital Market under the ticker symbol “PURR.”  The filing stated,

This move positions Hyperliquid alongside other companies that incorporate HYPE into their balance sheets, such as Eyenovia and Lion Group Holding. Adding altcoins has become a preferred choice for companies expanding beyond traditional holdings such as Bitcoin and Ethereum.

HYPE Token Surges Amid Filing Momentum

Following the filing, HYPE registered a strong increase in trading performance.  Token rose by 9.84% in the last 24 hours, trading at $38.82. Volume increased 16% to $672 million, indicating increased investor interest and renewed market interest.

HYPEUSDTSource: TradingView

Analysts are watching closely the new token unlocks starting in November. Around ten million HYPE tokens are expected to be unlocked every month until October 2027. Such unlocks usually cause price fluctuation in the market. However, sentiment among market analysts remains optimistic. 

An account on social media noted, 

Another analyst Aylo, expressed similar optimism, added, 

]]>
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like